Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bingjiu Lu
Observed names:
Bing-Jiu Lu,
Bing-jiu Lu,
Bingjiu LU
Institution:
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Observed institution:
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
ORCID:
0009-0006-3603-0676
Observed ORCID:
0009-0006-3603-0676
OpenAlex ID:
A5112908341
Gastrodia elata Blume: A review of its mechanisms and functions on cardiovascular systems
2023
·
Xiaoning Sun
, Bo Jia
, et al.
·
Fitoterapia
·
51
Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial
2020
·
Xiaoke Li
, Daqiao Zhou
, et al.
·
Hepatology International
·
19
New Insights into the Diagnosis and Treatment of Hepatocellular Carcinoma
2025
·
Chengbo Li
, Bingjiu Lu
, et al.
·
Biomedicines
·
15
PDF
Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
2020
·
Xiao-ke Li
, Ming-xiang Zhang
, et al.
·
Chinese Journal of Integrative Medicine
·
8
Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial
2018
·
Yong-an Ye
, Xiao-ke Li
, et al.
·
Chinese Journal of Integrative Medicine
·
8
Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multi-center, double-blind, randomized controlled trial in China
2020
·
Xiaoke Li
, Ludan Zhang
, et al.
·
Trials
·
5
PDF
Regression-based Chinese norms of number connection test A and digit symbol test for diagnosing minimal hepatic encephalopathy
2024
·
Peng Zhang
, Danan Gan
, et al.
·
Scientific Reports
·
4
PDF
Association of circadian syndrome with nonalcoholic fatty liver disease and liver fibrosis: A cross-sectional study based on NHANES 2017 to 2020.03 data
2026
·
Wenzhao Guo
, Sijia Li
, et al.
·
Medicine
·
2
Guideline for Traditional Chinese Medicine Diagnosis and Treatment of Primary Liver Cancer
2026
·
Xiuhui Li
, Xianbo Wang
, et al.
·
Gastroenterology and Hepatology Research
·
1
PDF
Cardio-hepatic axis in metabolic dysfunction-associated steatotic liver disease: Mechanisms, clinical implications and therapeutic opportunities
2026
·
Ran Zhao
, Jia-Lian Zheng
, et al.
·
World Journal of Hepatology
Association of combined high-sensitivity C-reactive protein and residual cholesterol levels with new-onset metabolic syndrome
2026
·
Shengnan Yue
, Hao Chen
, et al.
·
Archives of Medical Science
PDF
Advances on mechanisms and structural classification of Chinese herbal monomers against hepatocellular carcinoma
2026
·
Jia-Lian Zheng
, Pu-Zhao Chen
, et al.
·
World Journal of Gastroenterology
PDF
inical observation on modified Zeming Hongshan Decoction (泽明红山方) for metabolic associated fatty liver disease complicated with fatty acid metabolism disorders
2026
·
Xiaoxuan GENG
, Bingjiu LU
, et al.
·
Lishizhen Medicine and Materia Medica Research
PDF
Shengjiang Powder alleviates oxidative stress damage and fibrosis in mice with atherosclerosis concurrent with non-alcoholic fatty liver disease
2025
·
Jia He
, Bingjiu Lu
, et al.
·
Hereditas
PDF
Consolidation treatment with Tiaogan-Buxu-Jiedu granule (Traditional Chinese Medicine compound) plus entecavir reduces virological relapse following entecavir withdrawal in Chinese patients with chronic hepatitis B: a randomized, controlled trial
2023
·
Xiaoke Li
, Mei Qiu
, et al.
·
Journal of Hepatology
Utilizing machine learning-based predictive models to identify early virological recurrence in Chinese chronic hepatitis B patients following entecavir withdrawal
2023
·
Xiaoke Li
, Mei Qiu
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
16
Citation count:
113
H-index:
5
I10-index:
3
Year
Topic
Type